These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17719110)

  • 21. Are we ready for positron emission tomography/computed tomography-based target volume definition in lymphoma radiation therapy?
    Yeoh KW; Mikhaeel NG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):14-20. PubMed ID: 22578540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
    Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
    Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy volume delineation using 18F-FDG-PET/CT modifies gross node volume in patients with oesophageal cancer.
    Jimenez-Jimenez E; Mateos P; Aymar N; Roncero R; Ortiz I; Gimenez M; Pardo J; Salinas J; Sabater S
    Clin Transl Oncol; 2018 Nov; 20(11):1460-1466. PubMed ID: 29721766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
    Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG-PET scan and treatment planning for early stage Hodgkin lymphoma.
    Specht L
    Radiother Oncol; 2007 Nov; 85(2):176-7. PubMed ID: 17920143
    [No Abstract]   [Full Text] [Related]  

  • 30. Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma.
    Lee YK; Cook G; Flower MA; Rowbottom C; Shahidi M; Sharma B; Webb S
    Radiother Oncol; 2004 Dec; 73(3):277-83. PubMed ID: 15588871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
    Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P
    Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
    Schaefer NG; Hany TF; Taverna C; Seifert B; Stumpe KD; von Schulthess GK; Goerres GW
    Radiology; 2004 Sep; 232(3):823-9. PubMed ID: 15273335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
    El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of 18F-FDG PET-CT in the management of Hodgkin's lymphoma: preliminary results of a prospective study.
    Paolini R; Rampin L; Rodella E; Ramazzina E; Banti E; Al-Nahhas A; Rubello D
    Nucl Med Rev Cent East Eur; 2007; 10(2):87-90. PubMed ID: 18228212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome.
    Nielsen K; Maraldo MV; Berthelsen AK; Loft A; de Nully Brown P; Vogelius IR; Petersen PM; Specht L
    Radiother Oncol; 2020 Sep; 150():236-244. PubMed ID: 32622782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.
    Muijs CT; Beukema JC; Pruim J; Mul VE; Groen H; Plukker JT; Langendijk JA
    Radiother Oncol; 2010 Nov; 97(2):165-71. PubMed ID: 20541273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation.
    Ford EC; Lavely WC; Frassica DA; Myers LT; Asrari F; Wahl RL; Zellars RC
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):595-602. PubMed ID: 18394814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
    Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1385-92. PubMed ID: 15817341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma.
    Walker AJ; Chirindel A; Hobbs RF; Huynh-Le MP; Moore JA; Cho SY; Terezakis SA
    Pract Radiat Oncol; 2015; 5(4):219-27. PubMed ID: 26146182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
    Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
    Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.